Home → News & Events
Subscribe to our newsletter to stay up to date on the latest news, receive updates and invitations to events.
“Many breast cancer survivors report feeling left alone with questions once treatment ends.”
Speaking at an online seminar organised by Bröstcancerföreningen Amazona Stockholm, Eva Onjukka shared how #ProjectTETRIS is working to address a need voiced by patients themselves: providing personalised, relevant information about long-term risks to both patients and their doctors. @amazonasdecoracoes Karolinska Universitetssjukhuset @karolinskaunivsjukh
🩷At TETRIS, we are building tools that support more informed and proactive after treatment care.
#BreastCancer #Radiotherapy #PatientEngagement #DigitalHealth
“Many breast cancer survivors report feeling left alone with questions once treatment ends.”
Speaking at an online seminar organised by Bröstcancerföreningen Amazona Stockholm, Eva Onjukka shared how #ProjectTETRIS is working to address a need voiced by patients themselves: providing personalised, relevant information about long-term risks to both patients and their doctors. @amazonasdecoracoes Karolinska Universitetssjukhuset @karolinskaunivsjukh
🩷At TETRIS, we are building tools that support more informed and proactive after treatment care.
#BreastCancer #Radiotherapy #PatientEngagement #DigitalHealth
🎓 TETRIS Scientific Advisory Board: Prof. Alfons Hoekstra
Prof. Alfons Hoekstra, member of the TETRIS Scientific Advisory Board. Prof. Hoekstra is Associate Professor at the University of Amsterdam, where he is affiliated with the Computational Science Lab of the Informatics Institute, Faculty of Science and he also serves as Professor of Computational Biomedicine at ITMO University.
In the video below, Prof. Hoekstra explains one of the key concepts behind TETRIS: Digital Twins for Health.
Using a simple and intuitive example, he describes what a predictive model is by comparing it to a weather app. Just as we ask an app whether it will rain and whether we should take an umbrella, a digital twin uses data and predictive modelling to forecast how a patient`s condition may evolve and how different treatments might work.
But how is this translated in Healthcare?
🎥 Watch the video to learn more about what digital twins are, how predictive models work, and how these technologies can help improve patient care and treatment outcomes.
#TETRISProject #DigitalTwins #PersonalisedMedicine #HealthcareInnovation #ComputationalScience #ScientificAdvisoryBoard #EUResearch #DigitalHealth
🎓 TETRIS Scientific Advisory Board: Prof. Alfons Hoekstra
Prof. Alfons Hoekstra, member of the TETRIS Scientific Advisory Board. Prof. Hoekstra is Associate Professor at the University of Amsterdam, where he is affiliated with the Computational Science Lab of the Informatics Institute, Faculty of Science and he also serves as Professor of Computational Biomedicine at ITMO University.
In the video below, Prof. Hoekstra explains one of the key concepts behind TETRIS: Digital Twins for Health.
Using a simple and intuitive example, he describes what a predictive model is by comparing it to a weather app. Just as we ask an app whether it will rain and whether we should take an umbrella, a digital twin uses data and predictive modelling to forecast how a patient`s condition may evolve and how different treatments might work.
But how is this translated in Healthcare?
🎥 Watch the video to learn more about what digital twins are, how predictive models work, and how these technologies can help improve patient care and treatment outcomes.
#TETRISProject #DigitalTwins #PersonalisedMedicine #HealthcareInnovation #ComputationalScience #ScientificAdvisoryBoard #EUResearch #DigitalHealth
🇪🇺 TETRIS contributes to the European Virtual Human Twins Initiative
🔬 On 20-21 October 2026, TETRIS participated at the Annual Event of the Advanced Virtual Human Twins (VHT) Platform in Brussels, organised by the European Commission`s Directorate‑General for Communications Networks, Content and Technology (DG CONNECT), with the support of the VHTnet consortium.
As part of the Advanced VHT Platform User Group, TETRIS contributes to the discussions and collaborative work aimed at shaping a European platform for advanced Virtual Human Twins, supporting innovation in personalised medicine and healthcare.
🤝 The two-day event brought together researchers, developers, patient organisations, regulators and industry representatives to review progress and discuss the future platform`s development, focusing on:
- User needs and stakeholder engagement
- Interoperability and technical requirements
- Adoption, accessibility and trust, addressing barriers, capacity-building needs and ethical considerations.
For TETRIS, whose research explores the potential of Digital Twins to support personalised risk assessment of long-term side effects following breast cancer radiotherapy, contributing to this European initiative is an important opportunity to exchange knowledge, share expertise and help shape the future of patient-centred digital healthcare and collaboration across Europe is essential. @polimi @department.dmat.polimi Politecnico di Milano Fondazione IRCCS Istituto Nazionale dei Tumori @istituto_tumori @cmon_lab @vph_society
👉 To learn more about the event and the European VHT Platform, click here: https://digital-strategy.ec.europa.eu/en/events/advanced-virtual-human-twins-vht-platform-annual-event.
#TETRISproject #VirtualHumanTwins #DigitalTwins #PersonalisedMedicine #DigitalHealth #CancerResearch #EuropeanCommission
🇪🇺 TETRIS contributes to the European Virtual Human Twins Initiative
🔬 On 20-21 October 2026, TETRIS participated at the Annual Event of the Advanced Virtual Human Twins (VHT) Platform in Brussels, organised by the European Commission`s Directorate‑General for Communications Networks, Content and Technology (DG CONNECT), with the support of the VHTnet consortium.
As part of the Advanced VHT Platform User Group, TETRIS contributes to the discussions and collaborative work aimed at shaping a European platform for advanced Virtual Human Twins, supporting innovation in personalised medicine and healthcare.
🤝 The two-day event brought together researchers, developers, patient organisations, regulators and industry representatives to review progress and discuss the future platform`s development, focusing on:
- User needs and stakeholder engagement
- Interoperability and technical requirements
- Adoption, accessibility and trust, addressing barriers, capacity-building needs and ethical considerations.
For TETRIS, whose research explores the potential of Digital Twins to support personalised risk assessment of long-term side effects following breast cancer radiotherapy, contributing to this European initiative is an important opportunity to exchange knowledge, share expertise and help shape the future of patient-centred digital healthcare and collaboration across Europe is essential. @polimi @department.dmat.polimi Politecnico di Milano Fondazione IRCCS Istituto Nazionale dei Tumori @istituto_tumori @cmon_lab @vph_society
👉 To learn more about the event and the European VHT Platform, click here: https://digital-strategy.ec.europa.eu/en/events/advanced-virtual-human-twins-vht-platform-annual-event.
#TETRISproject #VirtualHumanTwins #DigitalTwins #PersonalisedMedicine #DigitalHealth #CancerResearch #EuropeanCommission
🎗️ Patients` Voices: Why Patient involvement matters in TETRIS
What motivates patients to contribute to scientific research? And how can their voices help shape better healthcare?
During our 3rd General Assembly in Stockholm, we asked members of the TETRIS Patient Advisory Board to share their experiences, perspectives and motivations for contributing to our research.
🎥 Through four video interviews, we heard from representatives of Bröstcancerföreningen Amazona Stockholm and Associazione Cuore di Donna, as well as patient representatives Raffaella Baldi and Enrica Globo.
From bringing patients` perspectives into scientific research to sharing personal experiences and contributing to the development of digital twins, their testimonies highlight one essential message:
Patients are not only beneficiaries of research. They are active contributors to scientific progress.
And that is what we do at TETRIS. We listen to Patients because they help us make research more inclusive, relevant and responsive to their real needs, with the ultimate goal of improving long-term care and quality of life.
👏 A heartfelt thank you to all our Patient Advisory Board members for their commitment and valuable contributions!
Read the full article with their testimonies here urlr.me/DzGHcc and watch all four interviews on our channels.
#TETRISproject #PatientsVoices #PatientEngagement #PatientAdvisoryBoard #BreastCancer #PatientCentredResearch #DigitalTwins
🎗️ Patients` Voices: Why Patient involvement matters in TETRIS
What motivates patients to contribute to scientific research? And how can their voices help shape better healthcare?
During our 3rd General Assembly in Stockholm, we asked members of the TETRIS Patient Advisory Board to share their experiences, perspectives and motivations for contributing to our research.
🎥 Through four video interviews, we heard from representatives of Bröstcancerföreningen Amazona Stockholm and Associazione Cuore di Donna, as well as patient representatives Raffaella Baldi and Enrica Globo.
From bringing patients` perspectives into scientific research to sharing personal experiences and contributing to the development of digital twins, their testimonies highlight one essential message:
Patients are not only beneficiaries of research. They are active contributors to scientific progress.
And that is what we do at TETRIS. We listen to Patients because they help us make research more inclusive, relevant and responsive to their real needs, with the ultimate goal of improving long-term care and quality of life.
👏 A heartfelt thank you to all our Patient Advisory Board members for their commitment and valuable contributions!
Read the full article with their testimonies here urlr.me/DzGHcc and watch all four interviews on our channels.
#TETRISproject #PatientsVoices #PatientEngagement #PatientAdvisoryBoard #BreastCancer #PatientCentredResearch #DigitalTwins